Key statistics
As of last trade ACADIA Pharmaceuticals Inc (DR6:STU) traded at 14.66, 9.94% above its 52-week low of 13.33, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.65 |
---|---|
High | 14.79 |
Low | 14.64 |
Bid | 14.69 |
Offer | 14.94 |
Previous close | 14.68 |
Average volume | 0.00 |
---|---|
Shares outstanding | 165.88m |
Free float | 164.99m |
P/E (TTM) | 90.56 |
Market cap | 2.72bn USD |
EPS (TTM) | 0.1813 USD |
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Press releases
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
- Ryan Reynolds Announces More to Parkinson’s® Campaign
- Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
- Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024
- Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med
More ▼